Finnish Agency Backs Bio Substitution But With Caveats
Executive Summary
A consultation exercise has convinced Finland’s Fimea medicines agency that pharmacy-level substitution of biologic drugs is viable. But several safeguards and conditions it is proposing could limit the effects of such substitution on uptake.